Gut Healing Stack
GUT HEALINGQuick Specifications
| Vial Size | 30MG TOTAL (3-PART ORAL PROTOCOL) |
|---|---|
| BAC Water | N/A — ALL ORAL TABLETS |
| Amount Per Unit | SEE INDIVIDUAL ENTRIES |
| Recommended Dose | SEE INDIVIDUAL PEPTIDE ENTRIES FOR PRECISE DOSING |
| Frequency | DAILY — LARAZOTIDE 3X DAILY BEFORE MEALS; BPC-157 AND KPV WITH MEALS |
| Injection Type | ORAL TABLETS ONLY |
| Timing | Larazotide: 30 min before each of 3 meals. BPC-157 Oral and KPV: taken with meals. All-oral stack for gut-specific targeting without systemic bypass. Can be run continuously or in 30-day cycles. See individual peptide entries (BPC-157 Oral Tablets, KPV, Larazotide) for specific dosing per component. |
Research Overview
The Gut Healing Stack combines three oral gut-targeted peptides into the most comprehensive all-oral gut research protocol available — each addressing a distinct mechanism of intestinal dysfunction with no mechanistic overlap. BPC-157 Oral Tablets provide tissue healing at the intestinal epithelium through VEGFR2-driven angiogenesis and ERK1/2-mediated endothelial repair signaling, accelerating recovery of physically damaged gut lining. KPV (a tripeptide fragment of alpha-MSH) addresses mucosal inflammation through melanocortin receptor (MC1R, MC3R) binding, reducing pro-inflammatory cytokines (IL-6, TNF-alpha, IL-1beta) and supporting mucosal barrier cell migration — particularly relevant for IBD, colitis, and intestinal inflammation. Larazotide (AT-1001) specifically targets tight junction structural integrity — the gatekeeping protein network of the gut barrier — by blocking zonulin-mediated junction disassembly and preventing increased intestinal permeability. Together, the three peptides address healing (BPC-157), inflammation (KPV), and barrier structure (Larazotide) — the three foundational layers of gut dysfunction — through mechanistically non-redundant pathways. The all-oral administration route is the defining feature of this stack: it enables direct targeting of the intestinal lining without systemic distribution, making it the only major research stack on this site that requires no injection. Larazotide is taken 30 minutes before meals; BPC-157 Oral and KPV are taken with meals. For research and educational purposes only.
Commonly Studied With
These peptides are frequently researched alongside Gut Healing Stack: BPC-157 Oral (10mg) / KPV (10mg) / Larazotide (10mg) due to complementary mechanisms:
For research-grade the Gut Healing Stack with third-party Certificate of Analysis documentation, Peptide Hub recommends Apollo Peptide Sciences. Apollo Peptide Sciences carries Larazotide, KPV, and BPC-157 for the Gut Healing Stack. Affiliate disclosure: we may earn a commission on purchases through this link.
Gut Healing Stack: BPC-157 Oral (10mg) / KPV (10mg) / Larazotide (10mg) information on this page is for research and educational purposes only. This content is not FDA-approved, does not constitute medical advice, and should not be used to guide personal health decisions. Consult a qualified healthcare professional before using any research compound.
Dose Calculator
Enter your target dose to calculate the volume to draw.
Recommended dose: SEE INDIVIDUAL PEPTIDE ENTRIES FOR PRECISE DOSING